Evidence map›Paper›PMID 40636637›Full record

ArticleCureus2025

Amelanotic Nodular Melanoma Over the Knee Region: A Case Report of a Diagnostic Challenge From the United Arab Emirates.

Khadiga Abdelmonem, Loay Ghalyoun, Divyashri Ramanathan Nagarajan, Sonia Otsmane, Joaquin Picazo-Yeste

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khadiga AbdelmonemMedicine, Burjeel Medical CIty, Abu Dhabi, ARE.
Loay GhalyounMedicine, Burjeel Medical City, Abu Dhabi, ARE.
Divyashri Ramanathan NagarajanMedicine, Burjeel Medical City, Abu Dhabi, ARE.
Sonia OtsmaneMedical Oncology, Burjeel Medical City, Abu Dhabi, ARE.
Joaquin Picazo-YesteGeneral Surgery, Burjeel Medical City, Abu Dhabi, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amelanotic melanoma (AM) is a rare and aggressive subtype of cutaneous melanoma that lacks the characteristic pigmentation, which makes it challenging to diagnose, often resulting in delayed treatment. Nodular melanoma (NM), a subtype of AM, is associated with a poorer prognosis and is infrequently reported in the Middle East and North Africa (MENA) region. AM is a rare and aggressive subtype of cutaneous melanoma, accounting for approximately 1-8% of all melanoma cases. We present the case of a 39-year-old Filipino female with a slowly enlarging, skin-colored lesion on her right patella, initially misdiagnosed as a dermatofibroma. The lesion was later confirmed as type IIIb cutaneous amelanotic nodular melanoma via histopathology and immunohistochemistry, with a Breslow thickness of 5 mm and Clark level IV invasion. Sentinel lymph node biopsy revealed nodal involvement, and the patient underwent wide local excision followed by adjuvant immunotherapy. This report highlights the diagnostic challenges posed by AM, particularly in younger patients and in regions where such cases are rarely reported. Accurate diagnosis requires a high index of suspicion and a multimodal diagnostic approach. Early recognition and intervention are crucial for improving patient outcomes in this aggressive malignancy.

Indexed as

knee lesionmisdiagnosisnodular melanomas: amelanotic melanomasentinel lymph nodeunited arab emirates

Identifiers

PMID40636637
PMCPMC12240450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.